Lipocine Inc (LPCN)
4.85
+0.14
(+2.97%)
USD |
NASDAQ |
May 02, 13:04
Lipocine Price: 4.85 for May 2, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 01, 2024 | 4.65 | 4.828 | 4.61 | 4.71 | 8946.00 |
Apr 30, 2024 | 4.71 | 4.79 | 4.54 | 4.62 | 28681.00 |
Apr 29, 2024 | 4.77 | 4.850 | 4.62 | 4.73 | 28711.00 |
Apr 26, 2024 | 4.52 | 4.810 | 4.51 | 4.798 | 19754.00 |
Apr 25, 2024 | 4.42 | 4.605 | 4.41 | 4.55 | 7982.00 |
Apr 24, 2024 | 4.79 | 5.02 | 4.40 | 4.44 | 66373.00 |
Apr 23, 2024 | 5.06 | 5.13 | 4.700 | 4.80 | 76675.00 |
Apr 22, 2024 | 5.19 | 5.40 | 5.030 | 5.07 | 21546.00 |
Apr 19, 2024 | 5.41 | 5.530 | 5.26 | 5.27 | 11286.00 |
Apr 18, 2024 | 5.24 | 5.53 | 5.22 | 5.44 | 21350.00 |
Apr 17, 2024 | 4.74 | 5.435 | 4.700 | 5.32 | 34899.00 |
Apr 16, 2024 | 5.30 | 5.30 | 4.68 | 4.76 | 37039.00 |
Apr 15, 2024 | 5.67 | 5.67 | 5.118 | 5.355 | 95973.00 |
Apr 12, 2024 | 6.11 | 6.25 | 5.52 | 5.81 | 214524.0 |
Apr 11, 2024 | 6.30 | 7.15 | 5.63 | 6.41 | 2.205M |
Apr 10, 2024 | 5.80 | 6.70 | 5.60 | 6.51 | 51900.00 |
Apr 09, 2024 | 5.335 | 5.88 | 5.335 | 5.77 | 96272.00 |
Apr 08, 2024 | 4.90 | 5.38 | 4.90 | 5.26 | 19761.00 |
Apr 05, 2024 | 4.58 | 4.822 | 4.53 | 4.80 | 23616.00 |
Apr 04, 2024 | 4.87 | 4.97 | 4.54 | 4.61 | 25305.00 |
Apr 03, 2024 | 5.02 | 5.075 | 4.93 | 4.93 | 4720.00 |
Apr 02, 2024 | 5.21 | 5.225 | 4.77 | 4.97 | 10661.00 |
Apr 01, 2024 | 5.11 | 5.30 | 5.02 | 5.30 | 13412.00 |
Mar 28, 2024 | 5.03 | 5.302 | 4.85 | 5.20 | 49035.00 |
Mar 27, 2024 | 4.95 | 5.30 | 4.95 | 5.129 | 20882.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.36
Minimum
Oct 30 2023
56.61
Maximum
Sep 09 2019
16.50
Average
15.14
Median
Price Benchmarks
Alpine Immune Sciences Inc | 64.60 |
Eliem Therapeutics Inc | 8.45 |
NovaBay Pharmaceuticals Inc | 0.0863 |
Palatin Technologies Inc | 1.97 |
iBio Inc | 1.99 |
Price Related Metrics
PEG Ratio | -0.0440 |
Price to Book Value | 1.266 |
Earnings Yield | -62.89% |
Market Cap | 25.78M |
PEGY Ratio | -0.0440 |